• Explore /
  • Poster
  • / Analysis of predictive clinical markers of outcome in patients with metastatic clear-cell renal cell carcinoma (mRCC) treated with tyrosine-kinases inhibitors (TKI) in first line: A C Camargo Cancer Center experience.

Analysis of predictive clinical markers of outcome in patients with metastatic clear-cell renal cell carcinoma (mRCC) treated with tyrosine-kinases inhibitors (TKI) in first line: A C Camargo Cancer Center experience.

Abstract Poster

Authors

null

Camila Nassif Martins Ferreira

A.C. Camargo Cancer Center, Sao Paulo, Brazil

Camila Nassif Martins Ferreira , José Augusto Rinck Jr., Christiane Silveira Marinho Albuquerque , Tatiana Vieira Costa , Ana Claudia Machado Urvanegia , Marcelo Corassa , Maria Nirvana Cruz Formiga , Aldo Lourenço Abbade Dettino , Milena Shizue Tariki , Flavio Augusto Ismael Pinto , Thiago Bueno Oliveira , Marcela Marinelli Salvadori

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Penile, Urethral, and Testicular Cancers; Renal Cell Cancer

Track

Renal Cell Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Renal Cell Cancer

Citation

J Clin Oncol 35, 2017 (suppl 6S; abstract 525)

DOI

10.1200/JCO.2017.35.6_suppl.525

Abstract #

525

Poster Bd #

G19

Abstract Disclosures

Similar Posters

First Author: Paolo Grassi

First Author: Sachdev P. Thomas

First Author: Pia Paffenholz

First Author: Austin Kalirai